Inpatient management of gamma-hydroxybutyrate withdrawal.

CONCLUSIONS:: There were low numbers attending for elective treatment for GHB use. Heavier GHB use predicted poor treatment retention. Polysubstance use and psychiatric co-morbidities need consideration in treatment planning. PMID: 30652947 [PubMed - as supplied by publisher]

https://www.ncbi.nlm.nih.gov/pubmed/30652947?dopt=Abstract

Source: Australasian Psychiatry - January 17, 2019 Category: Psychiatry Authors: Cappetta M, Murnion BP Tags: Australas Psychiatry Source Type: research